NYSE
232.67USD
-0.34 (-0.15%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
25.7B
P/E
—
EPS
—
Beta
0.57
52W range
170.53-240.13
Day range
230.65–233.99
Open
232.84
Prev close
233.01
Volume
338.6K
Avg volume
932.5K
Dividend
3.32
IPO
1996-12-17
https://www.zacks.com/stock/news/2966657/quest-diagnostics-raises-2026-outlook-as-testing-demand-accelerates?cid=CS-STOCKNEWSAPI-FT-analyst_blog_plus|zer_report_insights-2966657 · 8/3/2026+0.80
https://www.fool.com/investing/2026/07/26/why-quest-diagnostics-stock-climbed-this-past-week/ · 7/27/2026+1.00
https://www.prnewswire.com/news-releases/quest-diagnostics-reports-second-quarter-2026-financial-results-raises-revenue-and-eps-guidance-for-full-year-2026-302832675.html · 7/23/2026+1.00
https://www.prnewswire.com/news-releases/quest-diagnostics-now-the-largest-clinical-reference-lab-to-extend-oncology-test-access-through-oncoemr-mpi-302819760.html · 7/8/2026+0.80
https://seekingalpha.com/article/4905369-guardant-health-reveal-and-shield-driving-the-next-growth-phase · 5/15/2026
https://www.cnbc.com/2026/05/11/jim-cramer-todays-market-punishing-stocks-harder-than-1999.html · 5/11/2026-0.70
https://www.zacks.com/stock/news/2917548/bullish-quarterly-results-3-companies-raising-guidance?cid=CS-STOCKNEWSAPI-FT-stocks_in_the_news-2917548 · 5/7/2026+1.00
https://seekingalpha.com/article/4900604-quest-diagnostics-updating-levels-after-q1-earnings · 5/7/2026+0.60
https://www.reuters.com/business/healthcare-pharmaceuticals/quest-diagnostics-raises-full-year-forecast-posts-strong-quarter-testing-demand-2026-04-21/ · 4/21/2026+0.80
https://www.prnewswire.com/news-releases/quest-diagnostics-reports-first-quarter-2026-financial-results-raises-revenue-and-eps-guidance-for-full-year-2026-302747831.html · 4/21/2026+1.00
https://techcrunch.com/2026/03/27/whoop-has-lebron-now-it-wants-your-mom/ · 3/28/2026+0.50
https://www.zacks.com/commentary/2885115/4-outpatient-home-health-stocks-gaining-attention-amid-market-shifts?cid=CS-STOCKNEWSAPI-FT-industry_outlook-2885115 · 3/17/2026+0.60
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
